Related Experiment Video

Updated: Jan 4, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

289

Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?

Muller Fabbri1

  • 1University of Hawai'i Cancer Center, Cancer Biology Program, University of Hawai'i at Manoa, Honolulu, Hawaii. mfabbri@cc.hawaii.edu.

Cancer Research
|November 2, 2019
PubMed

Insights

Natural killer (NK) cells combat cancer, but tumors can evade them. NK cell-derived extracellular vesicles (EVs) show promise as anticancer agents, even in suppressive environments, offering new therapeutic strategies.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial cytotoxic lymphocytes that target virus-infected and cancerous cells.
  • Cancer cells employ immune-escape mechanisms to evade NK cell-mediated killing.
  • Specific signaling pathways modulate NK cell cytotoxicity against cancer.

Purpose of the Study:

  • To explore the potential of NK cell-derived extracellular vesicles (EVs) as a novel anticancer therapeutic strategy.
  • To investigate the efficacy of NK-derived EVs in overcoming tumor immune suppression.

Main Methods:

  • Analysis of NK cell function and immune evasion tactics.
  • Characterization of cargo (proteins, miRNAs) within NK cell-derived EVs.
  • Evaluation of antitumoral effects of NK-derived EVs in preclinical models.

Main Results:

  • NK cell-derived EVs possess proteins and miRNAs with demonstrated antitumoral activity.
  • These EVs can exert therapeutic effects within a highly immune-suppressive tumor microenvironment.
  • Evidence supports the potential of NK-derived EVs as a viable anticancer approach.

Conclusions:

  • NK cell-derived EVs represent a promising new avenue for cancer therapy.
  • Strategies to enrich NK-derived EVs with potent anticancer cargo are under development.
  • NK-derived EVs offer a potential solution to overcome tumor immune evasion.

More Related Videos

MicroRNA-based Regulation of Picornavirus Tropism09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

7.9K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

694

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K